Why the Father of Biohacking Now Uses LYMA (And Nothing Else)
"Lasers have always been more effective than LEDs, but they're expensive. So companies use LEDs because they're cheap." Dave Asprey
Asprey founded one of the first consumer LED companies. Tested everything. Then walked away. LEDs deliver 10% efficacy at best. Not enough for real cellular change.
The LYMA Laser PRO Is different. 808nm cold laser absorbed directly by your mitochondria. No trauma. No damage. Skin that functions younger. "Most treatments create scar tissue," Asprey explains. "You look better temporarily, but it's not healthy tissue."
"Better to signal cells: be younger."
That's what the LYMA Laser PRO does.
The LYMA Laser PRO: Molecular Biology, Not Marketing
"You've proven that 45 longevity genes are activated just by using LYMA. The SIRT1 activation blows away any supplement — and I take the supplements." — Dave Asprey
The clinical trial that changed everything.
Published in the Aesthetic Surgery Journal (2025), RNA sequencing measured what happens at the molecular level in human skin tissue.
The LYMA Laser PRO activated 45 genes. The LED device tested? 1 gene.
SIRT1 — the longevity gene — upregulated 6-fold. The gene Asprey wrote about in Super Human.
First published evidence of multi-gene longevity activation from any at-home device.
The results you can see. Transforms wrinkles, pigmentation, rosacea, scars, and elasticity. No trauma. No downtime. Peer-reviewed and proven.